141st APHA Annual Meeting

In This section

293740
Big tobacco strategies to undermine health through trade and civil society responses

Monday, November 4, 2013 : 11:20 AM - 11:35 AM

John Stewart , Corporate Accountability International, Boston, MA
The single greatest threat to the life-saving potential of the Framework Convention on Tobacco Control is tobacco industry interference in its implementation. A recent trend in industry interference is using trade and investment agreements to undermine tobacco control policies through international fora like the World Trade Organization, the World Bank, and new trade agreements being negotiated like the Trans-Pacific Partnership. This talk will focus on current Big Tobacco tactics to undermine health through trade and how civil society and public health professionals can take action to protect and prioritize public health over trade.

Learning Areas:
Advocacy for health and health education
Public health or related public policy

Learning Objectives:
Describe tobacco industry tactics to undermine tobacco control policies through trade and investment agreements Identify ways that civil society and public health professionals can expose and challenge these tactics

Keywords: Tobacco Industry, Tobacco Control

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Since 1994, Corporate Accountability International has worked to stop Big Tobacco from addicting new customers throughout the world and to block the industry from manipulating public policy to suit its own interests. Corporate Accountability International is in official relations with the World Health Organization (WHO), an accredited observer to the WHO Framework Convention on Tobacco Control Conference of the Parties, and also has Special Consultative Status with the United Nations Economic and Social Council.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.